First Header Logo Second Header Logo

Connection

Samuel Lentz to Disease Progression

Back to Details
This is a "connection" page, showing publications Samuel Lentz has written about Disease Progression.
Samuel Lentz
Connection Strength
0.012
Disease Progression
  1. Thigpen JT, Blessing JA, Olt G, Lentz SS, Bell J. Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study. Gynecol Oncol. 2003 Sep; 90(3):581-6.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.